ASX
Cynata Therapeutics Limited
CYP:ASX•Healthcare
Sensitive ASX Announcement
Phase 2 Trial of CYP-001 in aGvHD Approved in Turkey
Published: 07/12/23, 09:39am (AEST)•1 pages